John Primrose

23.8k total citations · 7 hit papers
230 papers, 12.8k citations indexed

About

John Primrose is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, John Primrose has authored 230 papers receiving a total of 12.8k indexed citations (citations by other indexed papers that have themselves been cited), including 115 papers in Oncology, 79 papers in Surgery and 65 papers in Pulmonary and Respiratory Medicine. Recurrent topics in John Primrose's work include Colorectal Cancer Treatments and Studies (58 papers), Hepatocellular Carcinoma Treatment and Prognosis (41 papers) and Gastric Cancer Management and Outcomes (29 papers). John Primrose is often cited by papers focused on Colorectal Cancer Treatments and Studies (58 papers), Hepatocellular Carcinoma Treatment and Prognosis (41 papers) and Gastric Cancer Management and Outcomes (29 papers). John Primrose collaborates with scholars based in United Kingdom, United States and Netherlands. John Primrose's co-authors include Graeme J. Poston, Mohammad Abu Hilal, Bernard Nordlinger, Philippe Rougier, Thomas Gruenberger, Meg Finch-Jones, Euan Walpole, Halfdan Sørbye, Bengt Glimelius and Wolf O. Bechstein and has published in prestigious journals such as The Lancet, JAMA and Nucleic Acids Research.

In The Last Decade

John Primrose

222 papers receiving 12.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

2008 1.4k citations Bernard Nordlinger, Bengt Glimelius et al. profile →
Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial

2013 853 citations Bernard Nordlinger, Bengt Glimelius et al. profile →
Surgical resection of hepatic metastases from colorectal cancer: A systematic review of published studies

2006 649 citations John Primrose et al. British Journal of Cancer profile →
Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors

2012 488 citations John Primrose et al. profile →
Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial

2017 331 citations John Primrose et al. profile →
Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline

2019 285 citations John Primrose, Juan W. Valle et al. Journal of Clinical Oncology profile →
Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

2022 278 citations John Bridgewater, John Primrose et al. Annals of Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John Primrose United Kingdom	56	7.0k	5.0k	4.4k	3.2k	2.0k	230	12.8k
Arndt Vogel Germany	55	4.5k 0.6×	4.1k 0.8×	4.6k 1.1×	3.1k 1.0×	3.0k 1.5×	384	12.9k
Akinobu Taketomi Japan	60	3.1k 0.4×	5.6k 1.1×	6.2k 1.4×	1.9k 0.6×	2.4k 1.2×	634	13.1k
Ken Shirabe Japan	62	4.8k 0.7×	6.7k 1.3×	8.2k 1.9×	2.8k 0.9×	2.7k 1.3×	859	17.4k
Hans J. Schlitt Germany	65	3.3k 0.5×	7.1k 1.4×	3.7k 0.9×	2.4k 0.8×	2.5k 1.2×	510	15.7k
Wolf O. Bechstein Germany	58	7.9k 1.1×	9.5k 1.9×	9.3k 2.1×	4.4k 1.4×	1.2k 0.6×	637	20.5k
Olivier Soubrane France	56	4.2k 0.6×	6.7k 1.3×	6.7k 1.5×	2.8k 0.9×	1.6k 0.8×	373	12.5k
Karl‐Walter Jauch Germany	58	4.2k 0.6×	3.7k 0.7×	1.2k 0.3×	2.1k 0.7×	3.0k 1.5×	229	11.4k
Winnie Yeo Hong Kong	63	6.5k 0.9×	2.5k 0.5×	7.3k 1.7×	2.7k 0.8×	2.6k 1.3×	423	17.7k
Adam C. Yopp United States	51	3.6k 0.5×	2.3k 0.5×	4.0k 0.9×	1.8k 0.6×	1.6k 0.8×	217	10.0k
P. Neuhaus Germany	59	5.0k 0.7×	9.3k 1.9×	8.4k 1.9×	3.2k 1.0×	1.2k 0.6×	596	18.0k

Countries citing papers authored by John Primrose

Since Specialization

Citations

This map shows the geographic impact of John Primrose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Primrose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Primrose more than expected).

Fields of papers citing papers by John Primrose

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Primrose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Primrose. The network helps show where John Primrose may publish in the future.

Co-authorship network of co-authors of John Primrose

This figure shows the co-authorship network connecting the top 25 collaborators of John Primrose. A scholar is included among the top collaborators of John Primrose based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Primrose. John Primrose is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Guest, Rachel V., Andrew D. Beggs, Eleanor Jaynes, et al.. (2025). 82P Genomic alterations in biliary tract cancer and association with patient outcomes: Translational data from patients treated on the randomised phase III multicentre BILCAP clinical trial. Annals of Oncology. 36. S226–S226.

Gootjes, Elske C., Barbara M. Zonderhuis, Kathelijn S. Versteeg, et al.. (2024). Primary outcome analysis of the ORCHESTRA trial: A randomized phase III trial of additional tumor debulking to first-line palliative systemic therapy for patients with multiorgan metastatic colorectal cancer.. Journal of Clinical Oncology. 42(17_suppl). LBA3502–LBA3502. 9 indexed citations

Guest, Rachel V., Andrew D. Beggs, Eleanor Jaynes, et al.. (2023). 106P The impact of alterations in cancer driver genes and other potentially targetable mutations on progression and overall survival in patients with biliary tract cancer treated on the randomised phase III multicentre BILCAP clinical trial. Annals of Oncology. 34. S222–S222.

Sijberden, Jasper P., John Primrose, Sachin Modi, et al.. (2023). Laparoscopic Right Hemihepatectomy after Future Liver Remnant Modulation: A Single Surgeon’s Experience. Cancers. 15(10). 2851–2851.

Jones, Robert, S. Pugh, Janet Graham, John Primrose, & Jorge Barriuso. (2021). Circulating tumour DNA as a biomarker in resectable and irresectable stage IV colorectal cancer; a systematic review and meta-analysis. European Journal of Cancer. 144. 368–381. 47 indexed citations

West, Malcolm, David P.J. van Dijk, Thomas Reeves, et al.. (2019). Myosteatosis is associated with poor physical fitness in patients undergoing hepatopancreatobiliary surgery. Journal of Cachexia Sarcopenia and Muscle. 10(4). 860–871. 53 indexed citations

Bastiaenen, Vivian P., Roberto Labianca, Anna Martling, et al.. (2018). Consensus and controversies regarding follow‐up after treatment with curative intent of nonmetastatic colorectal cancer: a synopsis of guidelines used in countries represented in the European Society of Coloproctology. Colorectal Disease. 21(4). 392–416. 23 indexed citations

Vecchio, Filippo Del, Rahul Bhome, S. Pugh, et al.. (2018). Long non-coding RNAs within the tumour microenvironment and their role in tumour-stroma cross-talk. Cancer Letters. 421. 94–102. 22 indexed citations

Nicholson, Brian, Bethany Shinkins, Nia Roberts, et al.. (2015). Blood CEA levels for detecting recurrent colorectal cancer: A Diagnostic Test Accuracy Review.. Oxford University Research Archive (ORA) (University of Oxford). 7 indexed citations

10.

Shinkins, Bethany, Nia Roberts, Susan Mallett, et al.. (2014). Blood CEA levels for detecting recurrent colorectal cancer (Protocol). White Rose Research Online (University of Leeds, The University of Sheffield, University of York). 8 indexed citations

11.

Zhang, Lei, Karen Pickard, Veronika Jenei, et al.. (2013). miR-153 Supports Colorectal Cancer Progression via Pleiotropic Effects That Enhance Invasion and Chemotherapeutic Resistance. Cancer Research. 73(21). 6435–6447. 119 indexed citations

12.

Bullock, Marc D., K. Pickard, Boye Schnack Nielsen, et al.. (2013). Pleiotropic actions of miR-21 highlight the critical role of deregulated stromal microRNAs during colorectal cancer progression. Cell Death and Disease. 4(6). e684–e684. 113 indexed citations

13.

Westwood, Greta, et al.. (2013). How to manage excess treatment costs. ePrints Soton (University of Southampton). 3 indexed citations

14.

Fabio, Francesco Di, Robert N. Whistance, Saqib Rahman, et al.. (2012). Exploring the Role of Laparoscopic Surgery in Two-Stage Hepatectomy for Bilobar Colorectal Liver Metastases. Journal of Laparoendoscopic & Advanced Surgical Techniques. 22(7). 647–650. 19 indexed citations

15.

Fuller, A, et al.. (2012). What is the incidence of resectable recurrence after surgery for primary colorectal cancer? Evidence from the UK FACS (Follow-up After Colorectal Surgery) trial. British journal of surgery. 99. 30–30. 1 indexed citations

16.

Conti, John A., Timothy J. Kendall, Adrian C Bateman, et al.. (2008). The Desmoplastic Reaction Surrounding Hepatic Colorectal Adenocarcinoma Metastases Aids Tumor Growth and Survival via αv Integrin Ligation. Clinical Cancer Research. 14(20). 6405–6413. 51 indexed citations

17.

George, S., Peter Pockney, John Primrose, et al.. (2008). A prospective randomised comparison of minor surgery in primary and secondary care. The MiSTIC trial. Health Technology Assessment. 12(23). iii–iv, ix. 38 indexed citations

18.

Nordlinger, Bernard, Laurence Collette, Marleen Praet, et al.. (2007). Survival after peri-operative chemotherapy with folfox 4 and surgery for resectable colorectal cancer liver metastases. Final results of the eortc intergroup randomized phase III study 40983. Annals of Oncology. 18. 1 indexed citations

19.

Corkhill, Andrea, et al.. (2004). Follow up after colorectal surgery (the FACS trial). British Journal of Cancer. 91. 1 indexed citations

20.

Perren, Timothy, et al.. (1997). A phase II study of recombinant interferon-β (r-hIFN-β 1a) in combination with 5-fluorouracil (5-FU) in the treatment of patients with advanced colorectal carcinoma. British Journal of Cancer. 75(3). 423–426. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact